Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA. - Wikidata - wikimedia - TriplyDB

Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA.

Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA.

http://www.wikidata.org/entity/Q35632848

about

The landscape of long noncoding RNAs in the human transcriptome A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serum Potential Utility of Novel Biomarkers in Active Surveillance of Low-Risk Prostate Cancer Recurrent rearrangements in prostate cancer: causes and therapeutic potential Comprehensive assessment for novel prostate cancer markers in the prostate-specific antigen era: focusing on Asians and Asian countries Urinary biomarkers for prostate cancer Novel RNA markers in prostate cancer: functional considerations and clinical translation A Quest to Identify Prostate Cancer Circulating Biomarkers with a Bench-to-Bedside Potential The emergence of lncRNAs in cancer biology Risk calculators and updated tools to select and plan a repeat biopsy for prostate cancer detection Structural and dynamic studies of the transcription factor ERG reveal DNA binding is allosterically autoinhibited How Precisely Can Prostate Cancer Be Managed?Meta-analysis of prostate cancer gene expression data identifies a novel discriminatory signature enriched for glycosylating enzymes Association of DSC3 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosis ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer Evolving transcriptomic fingerprint based on genome-wide data as prognostic tools in prostate cancer Sarcosine Up-Regulates Expression of Genes Involved in Cell Cycle Progression of Metastatic Models of Prostate Cancer.Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns.Androgen regulation of the TMPRSS2 gene and the effect of a SNP in an androgen response element Optical coding of fusion genes using multicolor quantum dots for prostate cancer diagnosis.The role of mRNA splicing in prostate cancer.The Xu's chart for prostate biopsy: a visual presentation of the added value of biomarkers to prostate-specific antigen for estimating detection rates of prostate cancer.New strategies in prostate cancer: translating genomics into the clinic The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer Interrogating genomic and epigenomic data to understand prostate cancer Evidence for molecular differences in prostate cancer between African American and Caucasian men Antibody-independent targeted quantification of TMPRSS2-ERG fusion protein products in prostate cancer.Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy Molecular pathways and targets in prostate cancer The ETS family of oncogenic transcription factors in solid tumours.The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc.Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer.A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancer.Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods.Fusion FISH imaging: single-molecule detection of gene fusion transcripts in situ.Prostate cancer marker panel with single cell sensitivity in urine.NGS catalog: A database of next generation sequencing studies in humans.Oncogenic activation of ERG: A predominant mechanism in prostate cancer.The transcription factor ERG increases expression of neurotransmitter receptors on prostate cancer cells.Urinary Volatile Organic Compounds for the Detection of Prostate Cancer

P2860

Q22122065-4C967432-B8F9-4382-83A2-8F9260C12320 Q24307894-9F0E8F9E-9CC3-4B0B-B000-B40DF657221E Q26784517-46B4B584-E575-4B20-9C07-E6387BF761E3 Q26851525-22D5ABE3-FD7A-49EF-BA66-FEF220496B21 Q26996461-ACC7F500-9420-47B1-9A98-AD8F8F72B2E2 Q27009110-D5A77BEE-3111-4709-AE1E-F3C5A229978D Q27021174-D17EF6B0-760A-4371-9BEB-86AD9161A637 Q27022638-C1DBE5EE-AB8A-47E9-87B3-4EE9448144A4 Q27024237-BD31B07B-2F39-4B29-86C8-D20BFDCB2552 Q27027085-B7ACC54A-8FDD-4293-BD39-9A5AC04DF22A Q27679276-605C5FB3-884C-410F-8672-CD92A6AE51A1 Q28078942-1DAD8008-5E6C-48F3-9E93-974138CB75E8 Q28085759-4386D0DB-F767-4CF2-9339-ABE0C7BA6EF3 Q28541425-9A431772-BA3C-4409-AEFB-5160C4437481 Q28771736-8AD479D7-760A-456B-9BE9-73003BAC8C30 Q30938412-5E98BECD-A19C-405F-AF1C-1F482C135A17 Q33364225-3056AE91-EB92-4103-83D6-D941DAD6EB45 Q33568125-972CBC6A-7848-442E-BA38-EC3BD1FB4E78 Q33663401-822FD05F-1956-4064-8733-7D5EA831E1A2 Q33812744-BF82CF7B-4B13-47D3-909A-FA32F5511374 Q33922376-C278A056-409B-4C49-98AE-5BB1EFEC8E94 Q33922385-7323961B-23C5-436B-A57E-F392458D42BF Q34007943-3B56C614-6CA1-46D2-84E4-098E6375CF4E Q34053956-C4B53F8F-72C7-4321-9F6D-B6AE54D8C7C2 Q34125866-0DC0D477-8B52-43BC-9375-14728D06FF2F Q34205227-DA9CA85E-BF5B-49E9-B3F8-576D0346494A Q34283031-9FD1DA00-6ECD-4A5E-B641-BCCF62432A6C Q34323314-F9FBFA49-326F-49B2-B988-74F742259D4D Q34365632-DC40E83F-40D8-491B-843A-9462057446D6 Q34555986-539B83B3-517B-43FD-A2CA-C29C1878C927 Q34558930-B5C7C85D-6191-4390-A59D-462C071B5577 Q34957004-04FA0C52-2639-4440-A64F-409FE3288EFD Q35022483-601C6DEB-DD19-4B77-9E47-A402CCC4E551 Q35125405-ABA75A2A-12D7-443E-A4EE-ADF06E230468 Q35133405-C6ECF854-2532-451A-B14D-CB7D9AE0DD08 Q35582373-B072F4AF-BB9C-4B22-8A71-B9276CE7F32D Q35607189-CF2D944B-F123-4D0D-B9FB-D1C23B05433F Q35685920-998482A5-470A-4D56-A64A-43D42BF453A7 Q35756563-051B958B-13A6-49FA-93A5-EDF6587C715A Q35849909-214BFEF2-874B-4F2D-A1EB-61291C391CB4

P2860

Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA.

http://www.wikidata.org/entity/Q35632848

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Urine TMPRSS2:ERG fusion trans ...... n men with elevated serum PSA.

@ast

Urine TMPRSS2:ERG fusion trans ...... n men with elevated serum PSA.

@en

type

label

Urine TMPRSS2:ERG fusion trans ...... n men with elevated serum PSA.

@ast

Urine TMPRSS2:ERG fusion trans ...... n men with elevated serum PSA.

@en

prefLabel

Urine TMPRSS2:ERG fusion trans ...... n men with elevated serum PSA.

@ast

Urine TMPRSS2:ERG fusion trans ...... n men with elevated serum PSA.

@en

P1433

Q35632848-262E4D53-B639-46D7-A5D8-F4AF3CC4A689

P1476

Q35632848-F611D418-B1E2-4220-9111-CF51D9C7E160

P2093

Q35632848-16055683-3D3C-405C-A3FA-1C577F69D2E9

Q35632848-1AA560DC-6AF6-4443-8C6B-3018AAA6B675

Q35632848-222A3C89-03A2-4CA6-A77D-94C6DDE2A11A

Q35632848-2233DD67-6883-41EC-9790-0BF7A1F9351E

Q35632848-27333368-9B87-4B97-9340-0591F18D989A

Q35632848-2BE09D9E-9240-49BC-9342-44741267B55C

Q35632848-35F9C03D-BA5F-4EEB-8535-DE05618D5764

Q35632848-3BE7B350-0DB7-4B41-9A1C-635352D3E3FB

Q35632848-41122345-8F5D-4A9D-B50C-AFCB6C7E718D

Q35632848-4AC698DD-DBD4-40B7-AB2A-786789ACFBEB

P2860

Q35632848-052F74AE-6585-484B-8183-205D13CD58FF

Q35632848-0977876F-2C67-4B3F-A676-A5363626B885

Q35632848-0D8F8E50-9A48-494F-99DC-0E6ADACA567F

Q35632848-10AF830C-9884-48DC-8A1C-CC31507D55CC

Q35632848-1A6AF5D5-1EB9-4BE9-B2F2-FEC23B6F32D6

Q35632848-219539F8-BC57-473C-BDD0-CCA18D064DDE

Q35632848-24778C1C-2C1F-4080-95BF-D50349E91EDD

Q35632848-309D153D-085E-441E-8136-131C86D52BC0

Q35632848-365844C8-0EB2-42C0-99A8-57B83E3AB11F

Q35632848-385F8398-EB81-4686-AB09-AE550B692D04

P304

Q35632848-95AAB322-6E45-4350-B0E2-1C8831A29E16

P31

Q35632848-AA9FBF9D-2A5E-4B9D-8D47-0A62BF87D681

P356

Q35632848-C655CB66-EBE9-44D0-ACC7-754682AF520B

P407

Q35632848-8338D269-A963-4621-9720-D75A04EBE6F7

P433

Q35632848-65636AA4-4B9B-49C6-86C1-B27F8D547C79

P478

Q35632848-C1790B33-EEB6-4F14-8E37-5070E76CC197

P50

Q35632848-383E2B03-E3E1-4A5C-BFC3-37931CA6175D

Q35632848-E3BC94BA-8CCD-4316-92EB-0F818300D989

P577

Q35632848-8621E837-0794-4875-B5B9-674EDBB6C3FF

P5875

Q35632848-9986CD86-9721-4932-A913-02DB56973478

P698

Q35632848-8082BC74-C0D6-479C-B1CB-58F1EE8CA7CB

P932

Q35632848-77DD6978-E3CF-4912-8FF7-6DB51E1A7D94

P356

SCITRANSLMED.3001970

P1433

Science Translational Medicine

P1476

Urine TMPRSS2:ERG fusion trans ...... n men with elevated serum PSA.

@en

P2093

Amy Blase

http://www.w3.org/2001/XMLSchema#string

Arul M Chinnaiyan

http://www.w3.org/2001/XMLSchema#string

Bo Han

http://www.w3.org/2001/XMLSchema#string

Brent Hollenbeck

http://www.w3.org/2001/XMLSchema#string

Daniel R Rhodes

http://www.w3.org/2001/XMLSchema#string

David Wood

http://www.w3.org/2001/XMLSchema#string

Harry Rittenhouse

http://www.w3.org/2001/XMLSchema#string

Jack Groskopf

http://www.w3.org/2001/XMLSchema#string

James B Amberson

http://www.w3.org/2001/XMLSchema#string

Javed Siddiqui

http://www.w3.org/2001/XMLSchema#string

P2860

A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer

Mortality results from a randomized prostate-cancer screening trial

Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Development of personalized tumor biomarkers using massively parallel sequencing

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

Screening and prostate-cancer mortality in a randomized European study

DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.

Antibody-based detection of ERG rearrangement-positive prostate cancer

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

P304

94ra72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.3001970

http://www.w3.org/2001/XMLSchema#string

P407

P433

94

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Nallasivam Palanisamy

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51544642

http://www.w3.org/2001/XMLSchema#string

P698

21813756

http://www.w3.org/2001/XMLSchema#string

P932

3245713

http://www.w3.org/2001/XMLSchema#string